Phase I study of VRCTC-310, a purified phospholipase A2 purified from snake venom, in patients with refractory cancer: safety and pharmacokinetic dataL.A. Marques Da Costa, Juan C. Cervellino, Horacio A. Miles et al.|Anti-Cancer Drugs|1997Cited by 26